These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35553393)

  • 1. COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional Study.
    Musche V; Bäuerle A; Jahre L; Schweda A; Dinse H; Moradian S; Weismüller B; Fink M; Wolters A; Fleischer M; Kleinschnitz C; Teufel M; Skoda EM; Stettner M
    Neurol Ther; 2022 Sep; 11(3):1135-1146. PubMed ID: 35553393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
    Baars AE; Kuitwaard K; de Koning LC; Luijten LWG; Kok WM; Eftimov F; Wieske L; Goedee HS; van der Pol WL; Blomkwist-Markens PH; Horemans AMC; Jacobs BC; van Doorn PA
    Neurology; 2023 Jan; 100(2):e182-e191. PubMed ID: 36127144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor neuron disease.
    van Rosmalen MHJ; Goedee HS; Derks R; Asselman FL; Verhamme C; de Luca A; Hendrikse J; van der Pol WL; Froeling M
    Eur J Neurol; 2021 Aug; 28(8):2716-2726. PubMed ID: 33934438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
    Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia.
    Park SB; Li T; Kiernan MC; Garg N; Wilson I; White R; Boggild M; McNabb A; Lee-Archer M; Taylor BV
    Muscle Nerve; 2022 Nov; 66(5):576-582. PubMed ID: 36054471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data.
    Merola A; Rosso M; Romagnolo A; Peci E; Cocito D
    Neurol Res Int; 2016; 2016():9478593. PubMed ID: 27313890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
    Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
    Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies.
    Doneddu PE; Briani C; Cocito D; Manganelli F; Fabrizi GM; Matà S; Mazzeo A; Fazio R; Benedetti L; Luigetti M; Inghilleri M; Ruiu E; Siciliano G; Cosentino G; Marfia GA; Carpo M; Filosto M; Antonini G; Notturno F; Sotgiu S; Cucurachi L; Dell'Aquila C; Bianchi E; Rosso T; Giordano A; Fernandes M; Campagnolo M; Peci E; Spina E; Tagliapietra M; Sperti M; Gentile L; Strano C; Germano F; Romozzi M; Moret F; Zarbo IR; Viola DV; Vegezzi E; Mataluni G; Cotti-Piccinelli S; Leonardi L; Carta A; Nobile-Orazio E;
    Eur J Neurol; 2023 Jul; 30(7):1907-1918. PubMed ID: 37000158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-Related Fear, Risk Perception, and Safety Behavior in Individuals with Diabetes.
    Musche V; Kohler H; Bäuerle A; Schweda A; Weismüller B; Fink M; Schadendorf T; Robitzsch A; Dörrie N; Tan S; Teufel M; Skoda EM
    Healthcare (Basel); 2021 Apr; 9(4):. PubMed ID: 33919519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory neuropathies and their impact on activities and participation.
    Wonink HA; Kruithof WJ; Goedee HS; Beelen A
    Eur J Neurol; 2023 Jul; 30(7):1928-1936. PubMed ID: 37038272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.
    Stettner M; Hinrichs L; Guthoff R; Bairov S; Petropoulos IN; Warnke C; Hartung HP; Malik RA; Kieseier BC
    Ann Clin Transl Neurol; 2016 Feb; 3(2):88-100. PubMed ID: 26900579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve Pathology Distinguishes Focal Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy From Multifocal Motor Neuropathy.
    Tracy JA; Taylor BV; Kiernan M; Dyck PJ; Crum BA; Mauermann ML; Amrami KK; Spinner RJ; Dyck PJB
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):1-10. PubMed ID: 32833719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.
    Garg N; Park SB; Howells J; Vucic S; Yiannikas C; Mathey EK; Nguyen T; Noto Y; Barnett MH; Krishnan AV; Spies J; Bostock H; Pollard JD; Kiernan MC
    Eur J Neurol; 2019 Aug; 26(8):1121-1129. PubMed ID: 30882969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the borderland of multifocal motor neuropathy and chronic inflammatory demyelinating polyradiculopathy.
    Topakian R; Müller P; Ciovica-Oel IC; Trenkler J
    Neurol Sci; 2021 Mar; 42(3):1131-1134. PubMed ID: 33074453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies.
    Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
    J Neurol Sci; 2015 Jan; 348(1-2):211-5. PubMed ID: 25534358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
    Racosta JM; Sposato LA; Kimpinski K
    Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in France: are daily practices in accordance with guidelines?
    Rosier C; Graveline N; Lacour A; Antoine JC; Camdessanché JP
    Eur J Neurol; 2019 Apr; 26(4):575-580. PubMed ID: 30326184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies.
    Oudeman J; Eftimov F; Strijkers GJ; Schneiders JJ; Roosendaal SD; Engbersen MP; Froeling M; Goedee HS; van Doorn PA; Caan MWA; van Schaik IN; Maas M; Nederveen AJ; de Visser M; Verhamme C
    Neurology; 2020 Jan; 94(1):e62-e74. PubMed ID: 31827006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity.
    Stascheit F; Hotter B; Klose S; Meisel C; Meisel A; Klehmet J
    Front Neurol; 2021; 12():723009. PubMed ID: 34589050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.